AAPL336.80-3.62 (-1.06%) ▼|ABBV276.11+3.69 (+1.35%) ▲|ABT99.60+1.11 (+1.13%) ▲|ACN208.89+0.53 (+0.25%) ▲|ADBE242.27+1.22 (+0.51%) ▲|AMAT507.03-2.54 (-0.50%) ▼|AMD608.10-12.58 (-2.03%) ▼|AMGN414.87+7.43 (+1.82%) ▲|AMT182.23+15.50 (+9.30%) ▲|AMZN262.43+8.37 (+3.29%) ▲|AVGO361.54+1.40 (+0.39%) ▲|AXP308.17+1.02 (+0.33%) ▲|BA190.41+2.66 (+1.42%) ▲|BAC54.31+0.70 (+1.31%) ▲|BKNG160.34+0.37 (+0.23%) ▲|BLK1,082.18+16.83 (+1.58%) ▲|BMY59.11-0.47 (-0.79%) ▼|BNY142.70-0.91 (-0.63%) ▼|BRK-B515.44+4.39 (+0.86%) ▲|C129.63+1.55 (+1.21%) ▲|CAT800.33+4.15 (+0.52%) ▲|CL88.26+0.16 (+0.18%) ▲|CMCSA20.66-0.55 (-2.59%) ▼|COF199.30-0.10 (-0.05%) ▼|COP134.10-0.09 (-0.07%) ▼|COST946.92-1.00 (-0.11%) ▼|CRM229.08+1.28 (+0.56%) ▲|CSCO118.39+3.50 (+3.05%) ▲|CVS86.17-1.63 (-1.86%) ▼|CVX211.98+0.43 (+0.20%) ▲|DE620.90-31.68 (-4.85%) ▼|DHR219.85+2.39 (+1.10%) ▲|DIS108.07+1.05 (+0.98%) ▲|DUK116.66-0.18 (-0.15%) ▼|EMR161.82+2.76 (+1.74%) ▲|FDX291.63-0.10 (-0.03%) ▼|GD331.30+2.99 (+0.91%) ▲|GE308.23+2.61 (+0.85%) ▲|GEV1,004.66+5.31 (+0.53%) ▲|GILD151.17+4.07 (+2.77%) ▲|GM82.72+0.47 (+0.57%) ▲|GOOG347.86+3.00 (+0.87%) ▲|GOOGL351.66+3.37 (+0.97%) ▲|GS895.69+13.10 (+1.48%) ▲|HD290.76-4.71 (-1.59%) ▼|HON207.73+1.13 (+0.55%) ▲|IBM227.10+0.49 (+0.22%) ▲|INTC104.70-2.38 (-2.22%) ▼|INTU302.75-1.13 (-0.37%) ▼|ISRG423.96+8.55 (+2.06%) ▲|JNJ261.49+5.01 (+1.95%) ▲|JPM333.02+1.60 (+0.48%) ▲|KO88.06+0.29 (+0.33%) ▲|LIN483.73+2.03 (+0.42%) ▲|LLY1,178.70+9.10 (+0.78%) ▲|LMT509.62+1.73 (+0.34%) ▲|LOW185.96-2.89 (-1.53%) ▼|LRCX318.84-1.75 (-0.55%) ▼|MA589.23+15.34 (+2.67%) ▲|MCD235.28-1.62 (-0.68%) ▼|MDLZ60.41-0.26 (-0.43%) ▼|MDT88.47+0.72 (+0.82%) ▲|META718.67-2.22 (-0.31%) ▼|MMM159.92-3.66 (-2.24%) ▼|MO71.68+0.26 (+0.36%) ▲|MRK145.57+3.19 (+2.24%) ▲|MS190.00+2.56 (+1.37%) ▲|MSFT535.07+12.46 (+2.38%) ▲|MU1,029.00-6.84 (-0.66%) ▼|NEE77.37+0.00 (+0.00%) ▲|NFLX70.30-1.27 (-1.77%) ▼|NKE34.72-0.02 (-0.06%) ▼|NOW140.87+1.12 (+0.80%) ▲|NVDA229.28-1.20 (-0.52%) ▼|ORCL141.53+6.34 (+4.69%) ▲|PEP125.97-2.37 (-1.85%) ▼|PFE28.27+0.45 (+1.62%) ▲|PG151.25+0.66 (+0.44%) ▲|PLTR209.05+10.27 (+5.17%) ▲|PM201.18+0.68 (+0.34%) ▲|QCOM175.50-0.51 (-0.29%) ▼|RTX185.95+1.63 (+0.88%) ▲|SBUX90.75-2.46 (-2.64%) ▼|SCHW96.71-0.16 (-0.17%) ▼|SO86.13-0.02 (-0.02%) ▼|SPG199.40-0.21 (-0.11%) ▼|T22.17-2.42 (-9.85%) ▼|TMO657.76+5.78 (+0.89%) ▲|TMUS148.58-22.73 (-13.27%) ▼|TSLA382.70+7.70 (+2.05%) ▲|TXN283.74-4.46 (-1.55%) ▼|UBER71.51+1.27 (+1.80%) ▲|UNH379.28+8.33 (+2.25%) ▲|UNP278.25+0.05 (+0.02%) ▲|UPS94.53+0.40 (+0.42%) ▲|USB57.07+0.04 (+0.07%) ▲|V385.51+10.41 (+2.77%) ▲|VZ41.65-3.99 (-8.75%) ▼|WFC83.57+1.54 (+1.88%) ▲|WMT111.35+0.79 (+0.71%) ▲|XOM169.01+0.51 (+0.30%) ▲|AAPL336.80-3.62 (-1.06%) ▼|ABBV276.11+3.69 (+1.35%) ▲|ABT99.60+1.11 (+1.13%) ▲|ACN208.89+0.53 (+0.25%) ▲|ADBE242.27+1.22 (+0.51%) ▲|AMAT507.03-2.54 (-0.50%) ▼|AMD608.10-12.58 (-2.03%) ▼|AMGN414.87+7.43 (+1.82%) ▲|AMT182.23+15.50 (+9.30%) ▲|AMZN262.43+8.37 (+3.29%) ▲|AVGO361.54+1.40 (+0.39%) ▲|AXP308.17+1.02 (+0.33%) ▲|BA190.41+2.66 (+1.42%) ▲|BAC54.31+0.70 (+1.31%) ▲|BKNG160.34+0.37 (+0.23%) ▲|BLK1,082.18+16.83 (+1.58%) ▲|BMY59.11-0.47 (-0.79%) ▼|BNY142.70-0.91 (-0.63%) ▼|BRK-B515.44+4.39 (+0.86%) ▲|C129.63+1.55 (+1.21%) ▲|CAT800.33+4.15 (+0.52%) ▲|CL88.26+0.16 (+0.18%) ▲|CMCSA20.66-0.55 (-2.59%) ▼|COF199.30-0.10 (-0.05%) ▼|COP134.10-0.09 (-0.07%) ▼|COST946.92-1.00 (-0.11%) ▼|CRM229.08+1.28 (+0.56%) ▲|CSCO118.39+3.50 (+3.05%) ▲|CVS86.17-1.63 (-1.86%) ▼|CVX211.98+0.43 (+0.20%) ▲|DE620.90-31.68 (-4.85%) ▼|DHR219.85+2.39 (+1.10%) ▲|DIS108.07+1.05 (+0.98%) ▲|DUK116.66-0.18 (-0.15%) ▼|EMR161.82+2.76 (+1.74%) ▲|FDX291.63-0.10 (-0.03%) ▼|GD331.30+2.99 (+0.91%) ▲|GE308.23+2.61 (+0.85%) ▲|GEV1,004.66+5.31 (+0.53%) ▲|GILD151.17+4.07 (+2.77%) ▲|GM82.72+0.47 (+0.57%) ▲|GOOG347.86+3.00 (+0.87%) ▲|GOOGL351.66+3.37 (+0.97%) ▲|GS895.69+13.10 (+1.48%) ▲|HD290.76-4.71 (-1.59%) ▼|HON207.73+1.13 (+0.55%) ▲|IBM227.10+0.49 (+0.22%) ▲|INTC104.70-2.38 (-2.22%) ▼|INTU302.75-1.13 (-0.37%) ▼|ISRG423.96+8.55 (+2.06%) ▲|JNJ261.49+5.01 (+1.95%) ▲|JPM333.02+1.60 (+0.48%) ▲|KO88.06+0.29 (+0.33%) ▲|LIN483.73+2.03 (+0.42%) ▲|LLY1,178.70+9.10 (+0.78%) ▲|LMT509.62+1.73 (+0.34%) ▲|LOW185.96-2.89 (-1.53%) ▼|LRCX318.84-1.75 (-0.55%) ▼|MA589.23+15.34 (+2.67%) ▲|MCD235.28-1.62 (-0.68%) ▼|MDLZ60.41-0.26 (-0.43%) ▼|MDT88.47+0.72 (+0.82%) ▲|META718.67-2.22 (-0.31%) ▼|MMM159.92-3.66 (-2.24%) ▼|MO71.68+0.26 (+0.36%) ▲|MRK145.57+3.19 (+2.24%) ▲|MS190.00+2.56 (+1.37%) ▲|MSFT535.07+12.46 (+2.38%) ▲|MU1,029.00-6.84 (-0.66%) ▼|NEE77.37+0.00 (+0.00%) ▲|NFLX70.30-1.27 (-1.77%) ▼|NKE34.72-0.02 (-0.06%) ▼|NOW140.87+1.12 (+0.80%) ▲|NVDA229.28-1.20 (-0.52%) ▼|ORCL141.53+6.34 (+4.69%) ▲|PEP125.97-2.37 (-1.85%) ▼|PFE28.27+0.45 (+1.62%) ▲|PG151.25+0.66 (+0.44%) ▲|PLTR209.05+10.27 (+5.17%) ▲|PM201.18+0.68 (+0.34%) ▲|QCOM175.50-0.51 (-0.29%) ▼|RTX185.95+1.63 (+0.88%) ▲|SBUX90.75-2.46 (-2.64%) ▼|SCHW96.71-0.16 (-0.17%) ▼|SO86.13-0.02 (-0.02%) ▼|SPG199.40-0.21 (-0.11%) ▼|T22.17-2.42 (-9.85%) ▼|TMO657.76+5.78 (+0.89%) ▲|TMUS148.58-22.73 (-13.27%) ▼|TSLA382.70+7.70 (+2.05%) ▲|TXN283.74-4.46 (-1.55%) ▼|UBER71.51+1.27 (+1.80%) ▲|UNH379.28+8.33 (+2.25%) ▲|UNP278.25+0.05 (+0.02%) ▲|UPS94.53+0.40 (+0.42%) ▲|USB57.07+0.04 (+0.07%) ▲|V385.51+10.41 (+2.77%) ▲|VZ41.65-3.99 (-8.75%) ▼|WFC83.57+1.54 (+1.88%) ▲|WMT111.35+0.79 (+0.71%) ▲|XOM169.01+0.51 (+0.30%) ▲|
22.6 C
New York
Friday, October 9, 2026

Tag: news

newssourceFORcompanyinformationcontent1releasesmarket

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former or Current 3M Company (NYSE:MMM) Investors Who Received Neogen Corporation (NASDAQ:NEOG) Shares in Connection With Neogen...

SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of former or current investors of 3M Company (“3M”) who received shares of Neogen Corporation (“Neogen” or the “Company”) in connection with Neogen’s acquisition of 3M’s Food Safety Business on September 1, 2022 (“Merger”).

Modified Cassava Starch Market worth $3.37 billion by 2030- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 23, 2025 /PRNewswire/ -- According to MarketsandMarkets™, The modified cassava starch market is projected to grow from USD 2.52 billion in...

IsoEnergy and Purepoint Extend High-Grade Mineralization at the Dorado JV with a 70 Metre Step-Out Peaking at 110,800 CPS

TORONTO, July 23, 2025 /CNW/ - IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) ("IsoEnergy") and Purepoint Uranium Group Inc. (TSXV: PTU) (OTC: PTUUF) ("Purepoint") are...

G Mining Ventures Provides Update on Gurupi Project Licensing Process in Brazil Following Court Ruling

BROSSARD, QC, July 23, 2025 /PRNewswire/ - G Mining Ventures Corp. ("GMIN" or the "Corporation") (TSX: GMIN) (OTCQX: GMINF) is pleased to announce that...

G Mining Ventures Provides Update on Gurupi Project Licensing Process in Brazil Following Court Ruling

BROSSARD, QC, July 23, 2025 /CNW/ - G Mining Ventures Corp. ("GMIN" or the "Corporation") (TSX: GMIN) (OTCQX: GMINF) is pleased to announce that...

IsoEnergy and Purepoint Extend High-Grade Mineralization at the Dorado JV with a 70 Metre Step-Out Peaking at 110,800 CPS

TORONTO, July 23, 2025 /CNW/ - IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) ("IsoEnergy") and Purepoint Uranium Group Inc. (TSXV: PTU) (OTC: PTUUF) ("Purepoint") are...

Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025

SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will...

GAC Group Named Official Vehicle Partner at 7th BRICS Media & Think Tank Forum

RIO DE JANEIRO, July 23, 2025 /PRNewswire/ -- The 7th BRICS Media and Think Tank Forum, co-hosted by Xinhua News Agency and Empresa Brasil...

4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock

Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial evaluating its monoclonal antibody, procizumab, in patients with shock caused primarily by cardiogenic events. Shock is a life-threatening condition characterized by a sudden breakdown in circulatory function due to end-stage disease or acute events, which often leads to organ failure. With only symptomatic treatment options available, shock is associated with a high mortality rate of over 50%. The Phase 1b/2a trial is designed to identify a target dose for procizumab in preparation for further clinical development. In addition, the trial will provide signals of efficacy. In a Phase 1 study in healthy volunteers, procizumab was well tolerated.

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 July 2025

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.

Dimensional Fund Advisors Ltd. : Form 8.3 – UNITE GROUP PLC/THE – Ordinary Shares

FORM 8.3

Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025

SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will...

Algorithmica Reports 35% Return in First Fiscal Year, Driven by Machine Learning Trading Technology

LUGANO, Switzerland, July 23, 2025 /PRNewswire/ -- Algorithmica, a cutting-edge technology provider of proprietary machine learning systems built upon the principles of Artificial Intelligence,...

Le Forum 2025 des journalistes de l’initiative « Belt and Road » entend « Promouvoir le dialogue des civilisations et la modernisation à l’échelle mondiale grâce au pouvoir...

GANZHOU, Chine, 23 juill. 2025 (GLOBE NEWSWIRE) -- Le Forum 2025 des journalistes de l’initiative « Belt and Road » (Une ceinture, une route) s’est tenu le 19 juillet à Ganzhou, dans la province du Jiangxi. Près d’une centaine de responsables d’organisations de journalistes et de représentants des médias de plus de 50 pays et régions se sont réunis pour échanger leurs points de vue sur le thème « Promouvoir le dialogue des civilisations et la modernisation à l’échelle mondiale grâce au pouvoir des journalistes ».

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNews

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers